May 2012 - FRMC

Drug Utilization Similar for Hepatitis C Dual and Triple Therapy

05/24/2012

San Francisco—The use of the protease inhibitors boceprevir or telaprevir in conjunction with peginterferon and ribavirin (known as triple therapy) for the treatment of type 1 hepatitis C did not result in increased drug utilization compared...

San Francisco—The use of the...

05/24/2012

First Report Managed Care

Challenges Associated with Multiple Myeloma and Myelofibrosis

05/24/2012

Tim Casey ;

San Francisco—As rare diseases, multiple myeloma and myelofibrosis, are difficult to manage and associated with high costs. Due to new therapies and evolving strategies that are effective but complex, the challenges are increasing. At the...

San Francisco—As rare diseases,...

05/24/2012

First Report Managed Care

Insurance Exchanges: Update for Managed Care Pharmacy

05/24/2012

Tori Socha ;

San Francisco—Provisions in the Patient Protection and Affordable Care Act (ACA) call for the establishment of insurance exchanges. These exchanges are intended to provide a competitive marketplace for individuals and employees of small...

San Francisco—Provisions in the...

05/24/2012

First Report Managed Care

Wall Street’s View of Healthcare Reform Initiatives

05/24/2012

Tim Casey ;

San Francisco—By 2020, healthcare expenditures in the United States are expected to reach nearly $5 trillion and account for 20% of the country’s gross domestic product (GDP), which is twice as much as in most developed countries. With an...

San Francisco—By 2020,...

05/24/2012

First Report Managed Care

Generic Step Therapy Program for Epilepsy Patients

05/24/2012

Eileen Koutnik-Fotopoulos ;

San Francisco—A step therapy program found that patients with epilepsy who switched to generic formulations had a numerically and statistically significant reduction in costs compared with patients who stayed on brand formulations, based on...

San Francisco—A step therapy...

05/24/2012

First Report Managed Care

Vemurafenib for BRAF V600+ Metastatic Melanoma

05/24/2012

Ken Palmer ;

San Francisco—Metastatic melanoma is a rare but rapidly progressing form of cancer that develops in the melanocytes of the skin. The BRAF protein kinase plays an important role in the progression of the disease. Vemurafenib is a BRAF...

San Francisco—Metastatic...

05/24/2012

First Report Managed Care

Comparative Effectiveness Research in Evaluating Lipid-Modifying Therapies

05/24/2012

Tim Casey ;

San Francisco—Managed care professionals are increasingly utilizing comparative effectiveness research (CER) to determine the effectiveness, safety, and value of drugs. This detailed approach is particularly useful for patients with high...

San Francisco—Managed care...

05/24/2012

First Report Managed Care

Department

Conference Insider

FDA Guidance on Unsolicited Requests for Off-Label Information

05/24/2012

Kristina Woodworth ;

San Francisco—During a Contemporary Issues session at the AMCP meeting, representatives from the FDA Office of Prescription Drug Promotion (OPDP) and the industry reviewed the FDA’s official Guidance for Industry on responding to unsolicited...

San Francisco—During a...

05/24/2012

First Report Managed Care

Conference Insider

Roadmap for Pharmacy HIT Integration

05/24/2012

Tori Socha ;

An advisory work group met to develop a Roadmap for pharmacists to follow to integrate health information technology (HIT) into their practice.

An advisory work group met to...

05/24/2012

First Report Managed Care

Conference Insider

Place-of-Service Management for Infusible Drugs

05/24/2012

Kevin L. Carter ;

San Francisco—Infliximab, a monoclonal antibody against tumor necrosis factor alpha (TNFα), is used to treat autoimmune conditions such as psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and...

San Francisco—Infliximab, a...

05/24/2012

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

The Pharmaceutical Pipeline: 2011 and Beyond

11/29/2011

Tori Socha ;

Atlanta—The number of drugs granted US Food and Drug Administration (FDA) approval decreased markedly in 2011 compared with other years. The FDA approval rate has slowed and the number of drugs under development has decreased, leading to a...

Atlanta—The number of drugs...

11/29/2011

First Report Managed Care

News

Buying Brand-Name Drugs Over Generics Raises Medicaid Costs

03/30/2011

First Report Managed Care

News

Consumer-directed health plans show mixed results

05/08/2012

First Report Managed Care

News

Low Rate of Endometrial Abnormalities in Women Taking Tamoxifen

06/09/2016

Findings from a new study may ease the minds of women taking tamoxifen for breast cancer, according to researchers at Loyola Medicine.

Findings from a new study may...

06/09/2016

First Report Managed Care

Headshots of Edmund Pezalla, Adam Kittai, Farrukh Awan, Jeffrey Dunn

Podcasts

Future of Care in CLL: Provider, Managed Care Perspectives

12/21/2022

Maria Asimopoulos ;

Adam Kittai, MD, hematology specialist and assistant professor of medicine, Ohio State University; Farrukh Awan, MD, professor of internal medicine, UT Southwestern Medical Center; and Jeffrey Dunn, PharmD, MBA, chief clinical officer,...

Adam Kittai, MD, hematology...

12/21/2022

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

May 2012 - FRMC

Department

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

May 2012 Volume 9 Issue 5

Specialties

Events

Year Round Education

HMP Global Products